Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin

By Hahn C. A.   Jones E. L.   Blivin J. L.   Sanders L. L.   Yu D.   Dewhirst M. W.   Secord A. A.   Prosnitz L. R.  

International Journal of Hyperthermia, Vol. 21, Iss. 4, 2005-06 ,pp. : 349-357

Informa Healthcare

Access to resources Recommend Favorite

Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial

By van Poznak C.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 3, 2001-04 ,pp. : 239-248

Springer Publishing Company

Access to resources Recommend Favorite

Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: a phase I/II study

By Hildebrandt B.   Dräger J.   Kerner T.   Deja M.   Löffel J.   Stroszczynski C.   Ahlers O.   Felix R.   Riess H.   Wust P.  

International Journal of Hyperthermia, Vol. 20, Iss. 3, 2004-05 ,pp. : 317-333

Informa Healthcare

Access to resources Recommend Favorite

Phase II Trial of Intraperitoneal Cisplatin with Intravenous Doxorubicin and Cyclophosphamide in Previously Untreated Patients with Advanced Ovarian Cancer-Long-Term Follow-Up

By Morgan R.J.   Braly P.   Cecchi G.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Parker P.   Stein A.   Cho J.   Smith E.   Coluzzi P.   Najera L.   Johnson D.   Womack E.   Doroshow J.H.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 419-426

Elsevier

Access to resources Recommend Favorite

A Phase I Study of a Daily x3 Schedule of Intravenous Vinorelbine for Refractory Epithelial Ovarian Cancer

By Gershenson D.M.   Burke T.W.   Morris M.   Bast R.C.   Guaspari A.   Hohneker J.   Wharton J.T.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 404-409

Elsevier

Access to resources Recommend Favorite